Nektar therapeutics latest stock news
WebApr 9, 2024 · In other Nektar Therapeutics news, CFO Jillian B. Thomsen sold 10,267 shares of the firm’s stock in a transaction on Thursday, February 16th. The stock was sold at an average price of $3.00, for ... WebFind the latest NKTR stock news. View the Nektar Therapeutics news and quotes for today, invesment news based on TipRanks market-leading research tools. ... Press Releases Nektar Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results. 12d ago. NKTR. The Fly Nektar reports Q4 EPS (32c), consensus (45c) 12d ago.
Nektar therapeutics latest stock news
Did you know?
WebApr 13, 2024 · Sarepta Therapeutics Inc ( SRPT) is down -6.73%% today. SRPT has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on SRPT! SRPT stock closed at $137.68 and is down -$9.26 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only … WebApr 12, 2024 · Nektar stock drops more than 30% after study involving lupus treatment will not go forward. Provided by Dow Jones Feb 23, 2024 10:25 PM UTC. PR Newswire.
WebApr 10, 2024 · NKTR Stock Overview. Nektar Therapeutics, a biopharmaceutical company, ... Recent News & Updates. Full year 2024 earnings: EPS exceeds analyst expectations Mar 01. Price target decreased by 21% to US$3.60 Feb 24. CEO, President & Director recently sold US$59k worth of stock WebGet the latest Nektar Therapeutics (NKTR) stock news and headlines to help you in your trading and investing decisions.
WebMar 18, 2024 · Other research analysts have also issued research reports about the stock. SVB Securities decreased their price target on shares of Nektar Therapeutics from $5.00 to $3.00 in a research report on ... WebApr 10, 2024 · The stock of Larimar Therapeutics has risen 31.5% in the past year. The consensus estimate for 2024 loss has narrowed from $2.07 per share to $1.08 per share …
WebApr 6, 2024 · Nektar Therapeutics, PureTech End Merger Talks - Quick Facts markets.businessinsider.com - October 11 at 3:54 AM: NKTR.P - Nektar Therapeutics …
WebNKTR: Get the latest Nektar Therapeutics stock price and detailed information including NKTR news, historical charts and realtime prices. city of malden ma employmentWebFind the latest Nektar Therapeutics (NKTR) stock quote, history, news and other vital information to help you with your stock trading and investing. door dash for groceriesWebApr 11, 2024 · For Immediate ReleaseChicago, IL – April 11, 2024 – Today, Zacks Equity Research discusses Catalyst Pharmaceuticals CPRX, KalVista Pharmaceuticals KALV, … doordash fredericton nbWebApr 10, 2024 · KalVista Pharmaceuticals recently completed a $58 million financing that will fund the company into 2025. The stock of KalVista Pharmaceuticals has declined 42.6% in the past year. The consensus ... door dash fort st johnWebApr 13, 2024 · Sarepta Therapeutics Inc ( SRPT) is down -6.73%% today. SRPT has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on … doordash for prime membersWebFeb 16, 2024 · I think Nektar is modestly undervalued now, with a fair value of around $3.75 on the basis of the two identified indications for Rezpeg and a placeholder for potential indications for NKTR-255 as ... city of malden ma online bill payWebApr 6, 2024 · 6 Wall Street research analysts have issued 1-year price objectives for Nektar Therapeutics' shares. Their NKTR share price forecasts range from $1.50 to $6.00. On … door dash for law enforcement